Diferencia entre revisiones de «Sodium Bicarbonate»
(Created page with "{{Dosing Variables}} ==Administration== *Type: 8.4% is common cardiac administered per *Dosage Forms: 5% ; 7.5% ; 8.4% ; 4.2% ; 4% ; 325 mg ; 150 mEq/1000 mL-D5% ; 150 mEq/115...") |
Sin resumen de edición |
||
| Línea 1: | Línea 1: | ||
==Administration== | ==Administration== | ||
*Type: 8.4% is common cardiac administered per | *Type: 8.4% is common cardiac administered per | ||
| Línea 5: | Línea 4: | ||
*Routes of Administration: IV | *Routes of Administration: IV | ||
*Common Trade Names: N/A | *Common Trade Names: N/A | ||
{{Dosing Variables}} | |||
==Adult Dosing== | ==Adult Dosing== | ||
===Cardiac Arrest=== | ===Cardiac Arrest=== | ||
Revisión del 21:53 22 oct 2015
Administration
- Type: 8.4% is common cardiac administered per
- Dosage Forms: 5% ; 7.5% ; 8.4% ; 4.2% ; 4% ; 325 mg ; 150 mEq/1000 mL-D5% ; 150 mEq/1150 mL-D5%
- Routes of Administration: IV
- Common Trade Names: N/A
Adult Dosing
Cardiac Arrest
50 mL (1 amp) IV push for severe acidemia and patient is adequately ventilated
IV drip
- 150 mEq/1000 mL inD5W
Pediatric Dosing
Cardiac Arrest
1 mL/kg IV push for severe acidemia and patient is adequately ventilated
Special Populations
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: